Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110372633B details a transition-metal-free reduction method using NaBEt3H, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN114522738B enables efficient 1,3-propanediol synthesis via Cu-catalysis. Delivers supply chain stability and cost reduction in polymer intermediate manufacturing.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Patent CN101056853B reveals a novel Pd-catalyzed regioselective hydrogenation route for isoindole derivatives, offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Discover the novel synthesis of 6-fluoro-2,4-diaminonitrobenzene via mild ammoniation. This patent-backed route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110028407A reveals a rare earth catalyzed method for spiro[cyclopropane-1,2'-indene]-1',3'-dione synthesis offering high stereoselectivity and supply chain advantages.
Patent CN104130092B details a novel one-step reductive coupling method. This breakthrough offers significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel LiI-promoted cyclization constructs aza[n.2.1] skeletons efficiently. Offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel sulfonyl-pyrrolidine route for Brivaracetam. Reduces chiral separation costs and simplifies purification for scalable API manufacturing.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel Ni(II)-SNC catalyst enables high-yield sulfide oxidation under mild conditions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN112921345B reveals a green electrochemical route for phosphorothioates, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Advanced synthesis of arylamine nitrogen mustard derivatives via patent CN106631857A. Offers reduced toxicity and enhanced therapeutic index for pharmaceutical manufacturing.
Patent CN104045513A reveals cost-effective Empagliflozin intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN116284117A introduces a green electrochemical route for thiophosphoramides, offering cost reduction and high purity for pharmaceutical and agrochemical manufacturing.
Patent CN106478325B details iridium catalyzed synthesis offering green chemistry benefits and supply chain reliability for high purity pharmaceutical intermediates manufacturing processes globally
Novel room-temperature copper catalysis for polychlorinated alkynes. Reduces energy costs and simplifies purification for high-purity pharmaceutical intermediates.
Patent CN105016938B reveals efficient N-alkyl amide synthesis. Low catalyst loading and commercial raw materials ensure cost reduction and supply reliability for pharmaceutical intermediates.
Novel NCS TEMPO oxidation method ensures stable scale-up and high purity for pharmaceutical intermediates manufacturing reducing cost and improving supply chain reliability significantly
Novel asymmetric synthesis patent CN119930414B offers high yield and purity. Reliable supplier for pharma intermediates with scalable processes.